| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.004 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |